Mozz is better with the factual details between trials differences but I believe one of the biggest issues with our Phase 2 was that we chose to use the FDA minimum dose recommendation (to appease them) and tick one of their boxes so it is less likely they send us back later to retest.
This phase 3 we are using PAR's recommended dosing with the FDA's blessing. So we should expect similar efficacy to the Phase 1 results which were outstanding... Mozz help a brother out.
The Pool
Mozz is better with the factual details between trials...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $112.9M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 28.5¢ | $431.5K | 1.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21578 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |